White Papers

APPLES, ORANGES AND AI

November 2024

A review of AI, where AI is going and its impact in healthcare and life sciences.

[ Read report ]
News & Commentary

Size Does Matter!

April 2024

Commercialization is key to success but the process starts with a deep understanding of the market opportunity.

[ Read Report ]
News & Commentary

The One-Handed Economist

August 2023

Our views on the economy and where the markets are headed next; which sectors (and sub-sectors) to invest in and which markets to avoid.

[ Read Report ]
News & Commentary

Sharpening R&D Focus

May 2023

Where is Big Pharma placing its bets? The upcoming ~$200B patent cliff and the stormy market conditions have significantly increased the pressure on Big Pharma to sustain pipelines while controlling costs. Most of the industry majors slashed their R&D budgets in 2022.

[ Read Report ]
News & Commentary

End of an Era

March 2023

The era of investing in unproven bets is gone, for the foreseeable future, and only the truly innovative and commercially minded will survive.

[ Read the article ]
White Papers

The Bullish Recession

September 2022

We believe that the “impending” recession is counterbalanced with strong economic data and once we start to peel the layers, we see a slightly different picture.

[ Read report ]
News & Commentary

Alléger les coûts de la bioproduction

July 2022

Reducing the costs of biologic manufacturing. (In french)

[ Read the article ]
News & Commentary

Irish America Business 100

June 2022

Mark Goldstone is named in 2022s Irish America Business 100.

[ View the article ]
News & Commentary

Investing in a promising early-stage healthcare company.

June 2022

Commercialization is key.

[ Read the article ]
News & Commentary

This downturn is different.

June 2022

"We should see a reasonably rapid recovery."

[ Listen to the broadcast ]
News & Commentary

Healthcare remains robust.

June 2022

Bloomberg Businessweek. Carol Massar and Tim Stenovec interview Youssef Sebban. May 31, 2022

[ Listen to the interview ]
White Papers

The Future of Wearable Healthtech.

April 2022

Reviews the innovation drivers and the dramatic growth potential of this very significant market.

[ Read report ]
White Papers

Investing In Early-Stage Healthcare Companies

April 2022

Looks at what's been driving the record investment into healthcare, what to look for and why commercialization is key.

[ Read report ]
News & Commentary
report

Size Does Matter!

April 2024

Commercialization is key to success but the process starts with a deep understanding of the market opportunity.

[ Read Report ]
News & Commentary

The One-Handed Economist

August 2023

Our views on the economy and where the markets are headed next; which sectors (and sub-sectors) to invest in and which markets to avoid.

[ Read Report ]
News & Commentary

Sharpening R&D Focus

May 2023

Where is Big Pharma placing its bets? The upcoming ~$200B patent cliff and the stormy market conditions have significantly increased the pressure on Big Pharma to sustain pipelines while controlling costs. Most of the industry majors slashed their R&D budgets in 2022.

[ Read Report ]
News & Commentary

End of an Era

March 2023

The era of investing in unproven bets is gone, for the foreseeable future, and only the truly innovative and commercially minded will survive.

[ Read the article ]
News & Commentary

Alléger les coûts de la bioproduction

July 2022

Reducing the costs of biologic manufacturing. (In french)

[ Read the article ]
News & Commentary

Irish America Business 100

June 2022

Mark Goldstone is named in 2022s Irish America Business 100.

[ View the article ]
News & Commentary

Investing in a promising early-stage healthcare company.

June 2022

Commercialization is key.

[ Read the article ]
News & Commentary

This downturn is different.

June 2022

"We should see a reasonably rapid recovery."

[ Listen to the broadcast ]
News & Commentary

Healthcare remains robust.

June 2022

Bloomberg Businessweek. Carol Massar and Tim Stenovec interview Youssef Sebban. May 31, 2022

[ Listen to the interview ]
White Papers
report

APPLES, ORANGES AND AI

November 2024

A review of AI, where AI is going and its impact in healthcare and life sciences.

[ Read report ]
White Papers
report

The Bullish Recession

September 2022

We believe that the “impending” recession is counterbalanced with strong economic data and once we start to peel the layers, we see a slightly different picture.

[ Read the Whitepaper ]
White Papers
report

The Future of Wearable Healthtech.

April 2022

Reviews the innovation drivers and the dramatic growth potential of this very significant market.

[ Read Report ]
White Papers
report

Investing In Early-Stage Healthcare Companies

April 2022

Looks at what's been driving the record investment into healthcare, what to look for and why commercialization is key.

[ Read Report ]